- Home
- / Celularity
Celularity
Stock Price
$1.7
2024-10-29
Market Capitalization
$37.6 M
2024-10-29
Revenue
$26.6 M
FY, 2025
Celularity Summary
Company Summary
- Overview
- Celularity is a biotechnology company developing allogeneic cells and tissues derived from the postpartum placenta. The cells are used to create transformative therapeutic options for complex medical conditions from cancer to Crohn’s disease.
- Type
- Public
- Status
- Active
- Founded
- 2016
- HQ
- Warren, NJ, US | view all locations
- Website
- https://www.celularity.com/
- Cybersecurity rating
Table of Contents
Key People
Robin Smith, Director
Peter H. Diamandis, Co-Founder and Vice Chairman
John Sculley, Director
LocationsView all
3 locations detected
Warren, NJ HQ
United States
33 Technology Dr S
Madison, NJ
United States
170 Park Ave
Carlton, VIC
Australia
Level 3/62 Lygon St
Celularity Financials
Summary Financials
- Revenue (FY, 2025)
- $26.6M
- Gross profit (FY, 2025)
- $6.5M
- Net income (FY, 2025)
- ($91.7M)
- Cash (FY, 2025)
- $6.2M
- EBIT (FY, 2025)
- ($61.3M)
- Enterprise value
- $58.3M